Chang, Julie E <br/><br/>
Rituximab and CHOP chemotherapy plus GM-CSF for previously untreated diffuse large B-cell lymphoma in the elderly: a Wisconsin oncology network study.  [electronic resource] 

 -  Clinical lymphoma, myeloma & leukemia  Oct 2010 
 - 379-84 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>2152-2669 
<br/><br/><label>Standard No.: </label>10.3816/CLML.2010.n.071  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Doxorubicin--administration & dosage<br/>Drug Synergism<br/>Female<br/>Granulocyte-Macrophage Colony-Stimulating Factor--administration & dosage<br/>Humans<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Male<br/>Middle Aged<br/>Prednisone--administration & dosage<br/>Rituximab<br/>Treatment Outcome<br/>Vincristine--administration & dosage